FDA's proposed $4.5 billion budget heavily depends on industry fees

02/13/2012 | DOTMed.com · Reuters

The FDA asked for a $4.5 billion budget for fiscal 2013, up 17%, or $654 million, from this year. Industry user fees, including proposed fees for generics and biosimilars, would account for 45% of the budget and would fund 98% of the increase in spending.

View Full Article in:

DOTMed.com · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY